Rubella vaccine, live-attenuated (Kexing (Dalian) Vaccine Technology)

风疹减毒活疫苗(人二倍体细胞)（科兴（大连）疫苗技术）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRubella vaccine, live-attenuated (Kexing (Dalian) Vaccine Technology)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRubella

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesSinovac (Dalian) Vaccine Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesSinovac (Dalian) Vaccine Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsRubella

Inactive IndicationsN/A

Other Information

ATC CodeN/A